4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001841401-26-000005
General Counsel acquired 24,236 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wahl Bryan General Counsel | 2026-03-15 | Option exercise | +24,236 | 76,399 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wahl Bryan General Counsel | 2026-03-15 | Option exercise · Restricted Stock Units | −4,790 | 0 | D: show line 2 in the form | ||
| Wahl Bryan General Counsel | 2026-03-15 | Option exercise · Restricted Stock Units | −7,248 | 7,249 | D: show line 3 in the form | ||
| Wahl Bryan General Counsel | 2026-03-15 | Option exercise · Restricted Stock Units | −7,176 | 14,351 | D: show line 4 in the form | ||
| Wahl Bryan General Counsel | 2026-03-15 | Option exercise · Restricted Stock Units | −5,022 | 15,067 | D: show line 5 in the form |
Loading xslF345X05/wk-form4_1773779905.xml…